IP Library Patent Application 19353455
Patent Application
App. No. 19/353,455

TISSUE SUBSTITUTE MATERIALS AND METHODS FOR TISSUE REPAIR

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/353,455
Abstract

Non-woven graft materials for use in specialized surgical procedures such as neurosurgical procedures, methods for making the non-woven graft materials, and methods for repairing tissue such as neurological tissue using the non-woven graft materials are disclosed. More particularly, disclosed are non-woven graft materials including at least two distinct fiber compositions composed of different polymeric materials, methods for making the non-woven graft materials and methods for repairing tissue in an individual in need thereof using the non-woven graft materials.

Claims (32)

1 - 20 . (canceled)

21 . A method of tissue repair in an individual in need thereof, comprising:

implanting a resorbable fiber matrix at a surgical site, the resorbable fiber matrix comprising:

a first non-woven fiber composition and a second non-woven fiber composition, the first and second non-woven fiber compositions each independently comprising a resorbable polymer;

wherein:

the resorbable fiber matrix has an architecture resembling a native extracellular matrix,

the resorbable fiber matrix has a tensile strength from about 1 Newton to about 15 Newtons, and

the implanted resorbable fiber matrix reinforces soft tissue where weakness exists.

22 . The method of claim 21 , wherein the resorbable fiber matrix is configured to resorb following tissue regeneration.

23 . The method of claim 21 , further comprising closing the surgical site after implantation.

24 . The method of claim 21 , further comprising securing the resorbable fiber matrix to the surgical site after implantation.

25 . The method of claim 24 , wherein the resorbable fiber matrix is secured to the surgical site by suture.

26 . The method of claim 21 , further comprising cutting the resorbable fiber matrix to fit the surgical site prior to implantation.

27 . The method of claim 21 , further comprising hydrating the resorbable fiber matrix prior to implantation.

28 . The method of claim 21 , wherein the resorbable fiber matrix comprises a plurality of pores comprising a mean pore size of from about 10 m 2 to about 300 m 2 .

29 . The method of claim 21 , wherein the first non-woven fiber composition and the second non-woven fiber composition each have a mean fiber diameter of less than 5 μm.

30 . The method of claim 21 , wherein the first non-woven fiber composition comprises poly(glycolic acid), poly(L-lactic acid), poly(lactic-co-glycolic acid), or combinations thereof.

31 . The method of claim 30 , wherein the second non-woven fiber composition comprises polycaprolactone, poly(L-lactide-co-p-caprolactone), poly(dioxanone), or combinations thereof.

32 . The method of claim 31 , wherein the first non-woven fiber composition comprises poly(lactic-co-glycolic acid) and the second non-woven fiber composition comprises poly(dioxanone).

33 . The method of claim 24 , wherein the first and second non-woven fiber compositions are configured to break down into one or more acidic byproducts when applied to a tissue site, and the one or more acidic byproducts are selected from the group consisting of monomers and oligomers comprising: lactic acid, glycolic acid, 6-hydroxycaproic acid, caproic acid, 4-hydroxybutyrate, 2-hydroxyethoxyacetic acid, glyoxylic acid, and oxalic acid.

34 . A resorbable fiber matrix comprising:

a first non-woven fiber composition and a second non-woven fiber composition, wherein the first and second non-woven fiber compositions each independently comprise a resorbable polymer;

wherein:

the resorbable fiber matrix has an architecture resembling a native extracellular matrix,

the resorbable fiber matrix has a tensile strength from about 1 Newton to about 15 Newton, and

the resorbable fiber matrix is configured for implantation to reinforce soft tissue where weakness exists.

35 . The resorbable fiber matrix of claim 34 , wherein the resorbable fiber matrix is configured to resorb following tissue regeneration.

36 . The resorbable fiber matrix of claim 34 , wherein the resorbable fiber matrix comprises a plurality of pores comprising a mean pore size of from about 10 μm 2 to about 300 m 2 .

37 . The resorbable fiber matrix of claim 34 , wherein the first non-woven fiber composition and the second non-woven fiber composition each have a mean fiber diameter of less than 5 m.

38 . The resorbable fiber matrix of claim 34 , wherein the first non-woven fiber composition comprises poly(glycolic acid), poly(L-lactic acid), poly(lactic-co-glycolic acid), or combinations thereof.

39 . The resorbable fiber matrix of claim 38 , wherein the second non-woven fiber composition comprises polycaprolactone, poly(L-lactide-co-F-caprolactone), poly(dioxanone), or combinations thereof.

40 . The resorbable fiber matrix of claim 39 , wherein the first non-woven fiber composition comprises poly(lactic-co-glycolic acid) and the second non-woven fiber composition comprises poly(dioxanone).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2026
From: ACERA SURGICAL, INC.
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 074933/0515 →
RELEASE OF SECURITY INTEREST Recorded Dec 23, 2025
From: WILSON FAMILY LEGACY TRUST NO. I
To: ACERA SURGICAL, INC.
Reel/Frame 073303/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2025
From: MACEWAN, MATTHEW
To: ACERA SURGICAL, INC.
Reel/Frame 072580/0811 →